Drug Profile
CNC 118
Alternative Names: CNC118; Genvax CNC118Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Cancure
- Class Cancer vaccines; Cell therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malignant melanoma
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Malignant-melanoma(Late-stage disease) in Australia (Parenteral, Injection)